R. McKenzie

777 total citations
9 papers, 496 citations indexed

About

R. McKenzie is a scholar working on Infectious Diseases, Endocrinology and Epidemiology. According to data from OpenAlex, R. McKenzie has authored 9 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Endocrinology and 3 papers in Epidemiology. Recurrent topics in R. McKenzie's work include Viral gastroenteritis research and epidemiology (4 papers), Escherichia coli research studies (4 papers) and Herpesvirus Infections and Treatments (3 papers). R. McKenzie is often cited by papers focused on Viral gastroenteritis research and epidemiology (4 papers), Escherichia coli research studies (4 papers) and Herpesvirus Infections and Treatments (3 papers). R. McKenzie collaborates with scholars based in United States and United Kingdom. R. McKenzie's co-authors include Martin Frank, Girish J. Kotwal, Carl H. Hammer, Bernard Moss, Stephen E. Straus, A. Louis Bourgeois, Allen Izu, Cornelia L. Dekker, Lawrence Corey and Rhonda G. Kost and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

R. McKenzie

9 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. McKenzie United States	8	224	164	127	117	96	9	496
Charlotta Bergquist Sweden	8	201 0.9×	94 0.6×	258 2.0×	81 0.7×	53 0.6×	8	505
Theresa M. Finn United States	14	168 0.8×	69 0.4×	52 0.4×	142 1.2×	32 0.3×	21	488
A Daas Belgium	11	112 0.5×	77 0.5×	68 0.5×	41 0.4×	45 0.5×	53	345
Jody D. Berry Canada	16	120 0.5×	366 2.2×	96 0.8×	55 0.5×	22 0.2×	28	634
Juan Arciniega United States	12	94 0.4×	88 0.5×	67 0.5×	45 0.4×	63 0.7×	29	421
Kazunori Morokuma Japan	13	106 0.5×	80 0.5×	115 0.9×	44 0.4×	122 1.3×	34	438
Peter McEvoy United States	11	166 0.7×	115 0.7×	68 0.5×	102 0.9×	13 0.1×	16	470
Paul Stickings United Kingdom	15	42 0.2×	96 0.6×	115 0.9×	140 1.2×	45 0.5×	37	483
Johanna Watkins United Kingdom	7	482 2.2×	123 0.8×	152 1.2×	110 0.9×	13 0.1×	9	749
Erik Beuken Netherlands	15	380 1.7×	55 0.3×	127 1.0×	32 0.3×	20 0.2×	22	611

Countries citing papers authored by R. McKenzie

Since Specialization

Citations

This map shows the geographic impact of R. McKenzie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. McKenzie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. McKenzie more than expected).

Fields of papers citing papers by R. McKenzie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. McKenzie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. McKenzie. The network helps show where R. McKenzie may publish in the future.

Co-authorship network of co-authors of R. McKenzie

This figure shows the co-authorship network connecting the top 25 collaborators of R. McKenzie. A scholar is included among the top collaborators of R. McKenzie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. McKenzie. R. McKenzie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Nayak, Seema, J. McLeod Griffiss, R. McKenzie, et al.. (2014). Safety and Pharmacokinetics of XOMA 3AB, a Novel Mixture of Three Monoclonal Antibodies against Botulinum Toxin A. Antimicrobial Agents and Chemotherapy. 58(9). 5047–5053. 47 indexed citations

McKenzie, R., Chad K. Porter, Joyce A. Cantrell, et al.. (2011). Volunteer Challenge With Enterotoxigenic Escherichia coli That Express Intestinal Colonization Factor Fimbriae CS17 and CS19. The Journal of Infectious Diseases. 204(1). 60–64. 19 indexed citations

Taylor, David N., R. McKenzie, Anna P. Durbin, et al.. (2006). Rifaximin, a Nonabsorbed Oral Antibiotic, Prevents Shigellosis after Experimental Challenge. Clinical Infectious Diseases. 42(9). 1283–1288. 50 indexed citations

Hall, Eric R., Roger Randall, R. McKenzie, et al.. (2005). Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of enterotoxigenic Escherichia coli in challenged and vaccinated volunteers. Vaccine. 24(18). 3709–3718. 36 indexed citations

McKenzie, R., Richard I. Walker, Gary S. Nabors, et al.. (2005). Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial. Vaccine. 24(18). 3735–3745. 61 indexed citations

Straus, Stephen E., Anna Wald, Rhonda G. Kost, et al.. (1997). Immunotherapy of Recurrent Genital Herpes with Recombinant Herpes Simplex Virus Type 2 Glycoproteins D and B: Results of a Placebo‐Controlled Vaccine Trial. The Journal of Infectious Diseases. 176(5). 1129–1134. 136 indexed citations

McKenzie, R. & Stephen E. Straus. (1996). Vaccine Therapy for Herpes Simplex Virus Infections: An Historical Perspective. Reviews in Medical Virology. 6(2). 85–96. 3 indexed citations

McKenzie, R. & Stephen E. Straus. (1995). Chronic fatigue syndrome.. PubMed. 40. 119–53. 16 indexed citations

McKenzie, R., Girish J. Kotwal, Bernard Moss, Carl H. Hammer, & Martin Frank. (1992). Regulation of Complement Activity by Vaccinia Virus Complement-Control Protein. The Journal of Infectious Diseases. 166(6). 1245–1250. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact